Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
HIV Viral Suppression Trends in the US
Ann Intern Med; ePub 2018 Aug 21; Nance, et al
Across the US, HIV viral suppression rates improved dramatically from 1997 to 2015, due in part to improved antiretroviral therapy (ART); however, disparities among young and black people living with HIV (PLWH) remain. This according to a recent longitudinal observational cohort study that evaluated viral suppression trends in PLWH in 8 HIV clinics across the US. Including the relationship of associated factors, such as demographic characteristics and integrase strand transfer inhibitor (ISTI) use. Viral suppression rates from 1997 to 2015 were determined. Researchers found:
- In tests among 31,930 PLWH, viral suppression increased from 32% in 1997 to 86% in 2015.
- Being older and using an ISTI-based regimen were associated with lower odds of having a detectable viral load (VL), and black race was associated with higher odds.
- Similar patterns were seen with continuous VL levels and with adjustment for adherence, substance use, or depression.
Nance RM, Delaney JC, Simoni JM, et al. HIV viral suppression trends over time among HIV-infected patients receiving care in the United States, 1997 to 2015: A cohort study. [Published online ahead of print August 21, 2018]. Ann Intern Med. doi:10.7326/M17-2242.
This Week's Must Reads
Must Reads in Infectious Diseases
Rapid Point of Care Test for Influenza, J Am Board Fam Med; 2019 Mar; Dale, et al
Invasive GBS Infections in Nonpregnant US Adults, JAMA Intern Med; ePub 2019 Feb 18; Francois Watkins, et al
Prescribed Opioids & Risk of CAP in Patients with HIV, JAMA Intern Med; 2019 Jan 7; Edelman, et al
Influenza Vaccination Safety During Hospitalization, Mayo Clin Proc; ePub 2019 Jan 8; Tartof, et al
Hospitalization Trends for Drug-Use Associated IE, Ann Intern Med; ePub 2018 Dec 4; Schranz, et al